• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·AJOY
Share

Ayujoy Herbals Ltd. Stocks

$ 0Last Updated 20.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 103731

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ayujoy Herbals Ltd. operates as a specialized research and testing organization, providing expert technical and regulatory consulting services. Their focus encompasses a wide array of products, including biotechnological innovations, pharmaceuticals, diagnostic instruments, and various medical equipment and devices. The company's primary clientele consists of pharmaceutical enterprises throughout India and Southeast Asia. Ayujoy Herbals' core objective is to assist these clients in navigating the complex process of securing FDA approval, thereby facilitating the export of their pharmaceutical, medical products, and devices to the United States market. Their extensive service portfolio covers essential aspects such as analytical quality control (QC) and quality assurance (QA) functions, preparation for regulatory inspections, and ensuring broad compliance. This also includes comprehensive validation services, clinical trial management, and professional guidance on regulatory and legal affairs. Specifically, they handle the meticulous preparation of regulatory filings, conduct compliance and risk assessments, and perform mock FDA audits. Additionally, Ayujoy Herbals offers specialized support for medical devices and Chemistry, Manufacturing, and Controls (CMC), provides Good Manufacturing Practice (GMP) training, and offers consulting for facility layout. The firm also expertly manages validation for utilities, processes, IT systems, computer systems, and cleaning procedures. Established in 2008, the company is headquartered in Mumbai, India.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is 'cheap' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 16:01

Highlights in Small-Cap Stocks: The Merck Deal, the Success of a Hair Loss Pill, and Braze's "Wow Factor"

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

24.10.2026 05:04

Hedge funds have ramped up their bets against the euro to a 2020 high

24.10.2026 04:46

France Avoided a Downgrade by Moody’s After a Week of Crisis

24.10.2026 04:37

A key Novartis drug failed to meet expectations. The stock price fell

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026